A limit of 5 mg was recently proposed as the European Pharmacopoeia limit for residual cyclohexanone in plastic containers for parenteral medical use with a nominal volume greater than 250 ml. Comparison of the proposed limit to published toxicological end-points and current governmental regulations was used to assess the potential risk following exposure. Based on the comparison, no adverse effects would be predicted from clinical exposures to 5 mg residual cyclohexanone in containers with a nominal volume of greater than 250 ml.
British Indiana Biological Research Association (BIBRA) International. 1991. Toxicity profile: Cyclohexanone, 1–10. Surrey, Great Britain: BIBRA.
2.
Greener, Y., L. Martis, and N. Indacochea-Redmond. 1982. Assessment of the toxicity of cyclohexanone administered intravenously to Wistar and Gunn rats. J. Toxicol. Environ. Health.10:385–396.
3.
International Agency for Research on Cancer (IARC). 1998. Cyclohexanone, CAS 108–94–1. In Hazardous substances database. IARC summary and evaluation: Monographs on the evaluation of the carcinogenic risk of chemicals to man. Geneva, Switzerland: IARC., World Health Organization.
4.
Koeferl, M. T., C. D. Port, P. J. Garvin, and J. L. Dorner. 1976. Subacute toxicity of cyclohexanone in rats, dogs, and monkeys. Toxicol. Appl. Pharmacol.37:115.
5.
Lijinsky, W., and R. M. Kovatch. 1986. Chronictoxicity study of cyclohexanone in rats and mice. J. Nat. Cancer Inst.77:941–949.
6.
Martis, L., T. Tolhurst, M. T. Koeferl, T. R. Miller, and T. D. Darby. 1980. Disposition kinetics of cyclohexanone in beagle dogs. Toxicol. Appl. Pharmacol.55:545–553.
7.
Pharmeuropa. 1995. Cyclohexanone. 7:203.
8.
Rees, D. C., and D. Hattis. 1994. Developing quantitative strategies for animal to human extrapolation. In Principles and methods of toxicology, third edition, ed. A. W. Hayes, 275–315. New York, NY: Raven Press.
9.
Registry of toxic effects of chemical substances. 1996. Cyclohexanone, CAS 108–94–1, RTECS accession number NIOSH/GW1050000, RTECS record number 29203. Last revision date: 10/96. Bethesda, MD: National Library of Medicine.
10.
U.S. Environmental Protection Agency (EPA): IRIS. 1992. Integrated risk information system. Cyclohexanone, CAS 108–94–1. Reference dose for oral exposure. IRIS No. 215. Last revision date: 1/22/92. Bethesda, MD: National Library of Medicine.